Insmed Incorporated Common Stock (NASDAQ: INSM) last traded at $100.60, up 0.12% on the session. The quote above updates while this page is open; the figures below are drawn from Insmed Incorporated Common Stock’s own filings and are restated only when a new one is published.
Insmed Incorporated Common Stock trades on NASDAQ under the ticker INSM. Its market capitalisation is $21.97 billion.
Valuation measures for Insmed Incorporated Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $21.97B |
|---|---|
| Enterprise value | $22.77B |
| Price / sales | 19.31 |
| Price / book | 29.00 |
| Beta | 0.54 |
Trailing-twelve-month figures tagged in Insmed Incorporated Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $1.14B |
|---|---|
| Net income (TTM) | -$875.31M |
| EPS (TTM) | -$4.12 |
| Gross margin | 83.46% |
| Operating margin | -73.89% |
| Return on equity | -115.55% |
| Cash | $544.76M |
Range and volume for INSM over the past 52 weeks.
| 52-week high | $212.75 |
|---|---|
| 52-week low | $90.39 |
| Volume | 2.47M |
| Average volume | 2.60M |
| Previous close | $100.48 |
Invest a chosen dollar amount in Insmed Incorporated Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell INSM.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.